Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference25 articles.
1. Lichtiger S, Present DH: Preliminary report: cyclosporine in treatment of severe active ulcerative colitis. Lancet 1990, 336:16–19.
2. Sandborn WJ: A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995, 1:48–63. Another superb Sandborn review. Meticulously detailed and authoritative review of all open-label and controlled CSA data in IBD. Although 4 years have passed since its publication, it is still timely and relevant.
3. Yoon C, Kornbluth A., George J, et al.: Is cyclosporine as effective in chronic ulcerative colitis as in severe ulcerativ colitis? Gastroenterology 1998, 114:G4586. Largest series of UC patients treated with CSA to date demonstrating equivalent short- and long-term response rates in different patient subsets. 6-MP is essential for long-term maintenance of remission.
4. Cohen RD, Stein R, Hanauer SB: Intravenous cyclosporine in ulcerative colitis: A five-year experience. Am J Gastroenterol 1999, 94:1587–1592.
5. Actis GC, Aimo G, Priolo G, et al.: Efficacy and efficiency o oral microemulsion cyclosporine versus intravenous and soft gelatin capsule cyclosporine in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm Bowel Dis 1998, 4:276–279. An important variation on standard oral CSA use. Fifteen patients with milder disease avoided the IV CSA phase with use of Neoral.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献